Policy

Icon
Icon

Drawing from Life: Alcohol in the time of COVID-19

Event Date
 - 
Online

Alcohol is a leading risk factor for death and disability worldwide. Drinking too much alcohol leads to health and social problems. During the COVID-19 pandemic, alcohol use has increased, particularly affecting those with long-term health conditions.

Alcohol Policy in Chile

Scientific article
Chile has one of the highest rates of alcohol use per capita in the Americas. Policy to reduce alcohol-related harm is often up against resistance from alcohol industry, policymakers and the public. This review, published in the Journal of...

Sixty-fourth session of the Commission on Narcotic Drugs (CND)

Event Date
 - 
Online

The sixty-fourth session of the Commission on Narcotic Drugs will be held from 12 to 16 April 2021.

In the light of the coronavirus disease (COVID-19) situation, the session is likely to be held in a hybrid format, combining in-person participation at the Vienna International Centre (VIC) and online participation. The CND meets every year to discuss the global state of drug control and to adopt resolutions to guide the way forward.

EU HCV Elimination Policy Summit

Event Date
 - 
Online

Despite the progress that has been made in recent years, HCV remains a major public health problem in Europe. In the European Union (EU) more people die each year from HCV than from HIV/AIDS. 

International Approaches to Drug Law Reform

Scientific article
This paper reviews the international evidence on approaches to drug law reform, focussing on case studies from Australia, Canada, Denmark, Portugal and The Netherlands. It seeks to support the ongoing development of innovative approaches to...

Alcohol-Related Violence and Deprivation

Event Date
 - 
Online

Scottish Health Action on Alcohol Problems (SHAAP) and Scottish Alcohol Research Network (SARN) warmly invite you to join us online on Tuesday 30 March from 12:30-14:00 BST for our third SHAAP/SARN Alcohol Occasionals event of 2021.

Dr Carly Lightowlers and Lucy Bryant will present their complementary research and we will then open to Q+A and wider discussion.